ResearcherPhilipps University of MarburgNo recent work listed
Kristopher K. Frese
Matched on ORCID iD 0000-0002-1369-0907; OpenAlex author ID A5033719663. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 34
2011: 1 paper · 2012: 3 papers · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper
Papers 8
- Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-19-1398↗
- PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulator… Co-author DOI 10.1158/0008-5472.can-15-0216↗
- Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. First author DOI 10.1038/bjc.2014.288↗
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2012-302529↗
- Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. First author DOI 10.1084/jem.20111923↗
- Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Co-author DOI 10.1136/gutjnl-2011-300850↗
- nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Co-author DOI 10.1158/2159-8290.cd-11-0242↗
- Stromal biology and therapy in pancreatic cancer. Co-author DOI 10.1136/gut.2010.226092↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David Arthur Tuveson · 7 shared papers, 2011–2019 · strength 0.26
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. DOI 10.1038/bjc.2014.288↗
- Paper nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic ca… DOI 10.1158/2159-8290.cd-11-0242↗
- Tashinga E. Bapiro · 5 shared papers, 2012–2019 · strength 0.20
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. DOI 10.1038/bjc.2014.288↗
- Paper nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic ca… DOI 10.1158/2159-8290.cd-11-0242↗
- Duncan Ian Jodrell · 5 shared papers, 2012–2019 · strength 0.20
- Paper Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-19-1398↗
- Paper Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. DOI 10.1038/bjc.2014.288↗
- Paper nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic ca… DOI 10.1158/2159-8290.cd-11-0242↗
- Natalie Cook · 6 shared papers, 2011–2014 · strength 0.19
- Paper Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. DOI 10.1038/bjc.2014.288↗
- Paper nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic ca… DOI 10.1158/2159-8290.cd-11-0242↗
- Paper Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. DOI 10.1136/gutjnl-2011-300850↗
- Albrecht Neeße · 4 shared papers, 2011–2014 · strength 0.13
- Paper Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. DOI 10.1038/bjc.2014.288↗
- Paper nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic ca… DOI 10.1158/2159-8290.cd-11-0242↗
- Paper Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. DOI 10.1136/gutjnl-2012-302529↗
- Lindsey A. Baker · 1 shared paper, 2019 · strength 0.07
- Mariano Ponz‐Sarvisé · 1 shared paper, 2019 · strength 0.07
- Iok In Christine Chio · 1 shared paper, 2019 · strength 0.07
- Vincenzo Corbo · 1 shared paper, 2019 · strength 0.07
- Tobiloba E. Oni · 1 shared paper, 2019 · strength 0.07
- Chang‐Il Hwang · 1 shared paper, 2019 · strength 0.07
- Dannielle D. Engle · 1 shared paper, 2019 · strength 0.07
- Youngkyu Park · 1 shared paper, 2019 · strength 0.07
- Kenneth H. Yu · 1 shared paper, 2019 · strength 0.07
- Hervé Tiriac · 1 shared paper, 2019 · strength 0.07
- Daniel Öhlund · 1 shared paper, 2019 · strength 0.07
- Malte Buchholz · 2 shared papers, 2011–2016 · strength 0.07
- Thomas Mathias Gress · 2 shared papers, 2011–2016 · strength 0.07
- Aarthi Gopinathan · 2 shared papers, 2012 · strength 0.06
- Michael A. Jacobetz · 2 shared papers, 2012–2013 · strength 0.06
- Christine Feig · 2 shared papers, 2011–2013 · strength 0.05
- Nathalia A. Giese · 1 shared paper, 2016 · strength 0.05
- Brajesh Pratap Kaistha · 1 shared paper, 2016 · strength 0.05
- Hans Armin Kestler · 1 shared paper, 2016 · strength 0.05
- Bence Sipos · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.